Lyell Immunopharma
201 Haskins Way,
San Francisco, 94080, CA,
United States
San Francisco, 94080, CA,
United States
1 702-514-4174
Life Sciences
Lyell Immunopharma Technographics
Lyell Immunopharma Technographics, Software Purchases, AI and Digital Transformation Initiatives
Discover the latest software purchases and digital transformation initiatives being undertaken by Lyell Immunopharma and its business and technology executives. Each quarter our research team identifies on-prem and cloud applications that are being used by the 219 Lyell Immunopharma employees from the public (Press Releases, Customer References, Testimonials, Case Studies and Success Stories) and proprietary sources.
During our research, we have identified that Lyell Immunopharma has purchased the following applications: Oracle Cloud ERP for ERP Financial in 2019, Benchling Bioresearch for Laboratory Management in 2023, Google Workspace (Formerly Google G-Suite) for Collaboration in 2019 and the related IT decision-makers and key stakeholders.
Our database provides customer insight and contextual information on which enterprise applications and software systems Lyell Immunopharma is running and its propensity to invest more and deepen its relationship with Oracle , Benchling , Google or identify new suppliers as part of their overall Digital and IT transformation projects to stay competitive, fend off threats from disruptive forces, or comply with internal mandates to improve overall enterprise efficiency.
We have been analyzing Lyell Immunopharma revenues, which have grown to $10.7 million in 2024, plus its IT budget and roadmap, cloud software purchases, aggregating massive amounts of data points that form the basis of our forecast assumptions for Lyell Immunopharma intention to invest in emerging technologies such as AI, Machine Learning, IoT, Blockchain, Autonomous Database or in cloud-based ERP, HCM, CRM, EPM, Procurement or Treasury applications.
Lyell Immunopharma Tech Stack and Enterprise Applications
Lyell Immunopharma ERP
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Oracle | Legacy | Oracle Cloud ERP | ERP Financial | ERP | n/a | 2019 | 2020 |
In 2019 Lyell Immunopharma implemented Oracle Cloud ERP as its core finance system under the ERP Financial category, deploying Oracle Fusion ERP configurations to centralize and standardize financial operations. The implementation was positioned to support critical SEC readiness activities and IPO preparations, with explicit workstreams for S-1 review, schedule preparation and financial tie-outs.
The deployment concentrated on core financial modules and structured workflows, with configuration of general ledger controls, accounts payable processing, month-end close calendars and checklists, journal entry review procedures, and account reconciliation workflows. Functional coverage included revenue and expense accounting treatments aligned to ASC 320, 606, 730 and 810, and the preparation and review of accounting memos for complex transactions.
Operational ownership extended to a finance team of five responsible for GL accounting, financial reporting and accounts payable, and included development of accounting policies, scalable processes and procedures as the company grew. The Oracle Cloud ERP implementation supported ongoing governance work, including establishment and maintenance of internal control activities within the areas of responsibility, facilitation of the annual audit and tax return processes, and management of the annual R and D tax credit study.
Implementation activities emphasized cross-functional collaboration, with finance liaising across the organization and with ecosystem partners to surface transaction details and reporting requirements. The Oracle Cloud ERP deployment served as the backbone for Lyell Immunopharma finance and accounting functions, enabling structured monthly close execution, S-1 level schedule generation and sustained control documentation.
|
Lyell Immunopharma ERP Services and Operations
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Benchling | Legacy | Benchling Bioresearch | Laboratory Management | ERP Services and Operations | n/a | 2023 | 2023 |
In 2023, Lyell Immunopharma deployed Benchling Bioresearch as a central system of record for Research and Development teams in a Laboratory Management context to standardize collaboration and data quality across cell therapy programs. The implementation was positioned to support Lyell’s mission of developing T-cell therapies for solid tumors by providing a cloud-native, extensible platform with a RESTful API and data warehouse connectivity.
The deployment included core Benchling Bioresearch capabilities such as an electronic lab notebook, Benchling Studies for in vivo experiment design and capture, structured sample and inventory management, sequence integrity tracking, and templated data collection. Configuration emphasized reusable templates, automated task management, multi-parameter randomization for in vivo studies, and automated dashboards and reports to reduce manual steps in data review.
Architecturally the solution is cloud-native and leverages Benchling’s flexible data model, RESTful API, and data warehouse features to integrate experimental context with instrument data and Lyell’s data lake. Benchling Bioresearch was implemented as a single searchable repository that consolidates candidate product identity, container entities, and experiment metadata to enable traceability and centralized access for scientists and information sciences teams.
Operational coverage focused on Research and Development, including Next-Gen Sequencing and the in vivo team, with processes standardized across sites to manage resources and sample utilization. Governance changes included deployment of standardized templates to ensure reproducibility, configuration-driven workflows to enforce data capture and task sequencing, and data stewardship practices to maintain sequence integrity and inventory traceability.
Outcomes reported by Lyell are improved data quality through reduced data-related errors, faster time to insights from automatic dashboards and reports, and increased productivity with teams reporting three times faster search, collation, and analysis. The centralized Benchling Bioresearch repository also supports regulatory deliverables by providing contextualized end-to-end records used for IND filings and program reporting.
|
Lyell Immunopharma Collaboration
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
| Legacy | Google Workspace (Formerly Google G-Suite) | Collaboration | Collaboration | n/a | 2019 | 2019 |
In 2019, Lyell Immunopharma implemented Google Workspace (Formerly Google G-Suite) to provide enterprise Collaboration capabilities across the organization. Lyell Immunopharma deployed Google Workspace (Formerly Google G-Suite) to support corporate communications, document collaboration, and calendar scheduling for research and administrative teams, establishing a single productivity platform for email, calendar, and content creation.
The deployment leverages standard Google Workspace modules including Gmail, Google Calendar, Google Drive, Google Docs, and the Google Admin console, enabling centralized user and access management, shared drives, and collaborative document workflows. Implementation scope covers corporate and R&D business functions and is visible via public site signals on Lyell's website, indicating organization-wide provisioning and administrative governance for user provisioning and shared content collaboration.
|
Lyell Immunopharma SCM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Supply Chain Management | SCM |
|
2020 | 2021 |
|
Lyell Immunopharma CRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Customer Experience | CRM |
|
2021 | 2021 |
|
|
|
|
|
Customer Support | CRM |
|
2019 | 2019 |
|
Lyell Immunopharma ITSM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
IT Service Management | ITSM |
|
2021 | 2021 |
|
Lyell Immunopharma TRM
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Governance, Risk and Compliance | TRM |
|
2021 | 2021 |
|
Lyell Immunopharma IaaS
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Application Hosting and Computing Services | IaaS |
|
2021 | 2021 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2021 | 2021 |
|
|
|
|
|
Content Delivery Network | IaaS |
|
2021 | 2021 |
|
Lyell Immunopharma CyberSecurity
Vendor |
Previous System |
Application |
Category |
Market |
VAR/SI |
When |
Live |
Insight |
|---|---|---|---|---|---|---|---|---|
|
|
|
|
Cloud Access Security Brokers (CASB) | CyberSecurity |
|
2023 | 2023 |
|
|
|
|
|
Identity and Access Management (IAM) | CyberSecurity |
|
2021 | 2021 |
|
IT Decision Makers and Key Stakeholders at Lyell Immunopharma
| First Name | Last Name | Title | Function | Department | Phone | |
|---|---|---|---|---|---|---|
|
|
VP Finance | VP | Finance | |
|
|
|
Associate Director, Finance | Director | Finance | |
|
|
|
Director, Corporate IT | Director | Finance | |
|
|
|
Associate Director, Procurement | Director | Procurement | |
|
Apps Being Evaluated by Lyell Immunopharma Executives
APPS RUN THE WORLD tracks software evaluation trends across 2 million companies worldwide, including buyer insights from Lyell Immunopharma IT executives and key decision makers. As part of ARTW Buyer Intent and technographics insights, these findings provide useful visibility into the Lyell Immunopharma digital transformation priorities and AI adoption trends.
| Date | Company | Status | Vendor | Product | Category | Market |
|---|---|---|---|---|---|---|
| No data found | ||||||
FAQ - APPS RUN THE WORLD Lyell Immunopharma Technographics
Lyell Immunopharma is a Life Sciences organization based in United States,
with around 219 employees and annual revenues of $10.7 million.
Lyell Immunopharma operates a diverse technology stack with applications such as
Oracle Cloud ERP, Benchling Bioresearch and Google Workspace (Formerly Google G-Suite),
covering areas like ERP Financial, Laboratory Management and Collaboration.
Lyell Immunopharma has invested in cloud applications and AI-driven platforms to optimize efficiency and growth,
collaborating with vendors such as Oracle, Benchling and Google.
Lyell Immunopharma recently adopted applications including
Benchling Bioresearch in 2023, Fidelis Halo in 2023 and FullStory in 2021,
highlighting its ongoing modernization strategy.
APPS RUN THE WORLD maintains an up-to-date database of Lyell Immunopharma’s key decision makers and IT executives,
available to Premium subscribers.
Our research team continuously updates Lyell Immunopharma’s profile with verified software purchases,
vendor relationships, and digital initiatives identified from public and proprietary sources.
Subscribe to APPS RUN THE WORLD to access the complete Lyell Immunopharma technographics profile,
including detailed breakdowns by category, vendor, and IT decision makers.